logo

Europe Insulin Pens Market Size (2024 - 2029)

The Europe Insulin Pens Market is projected to experience growth over the forecast period, driven by various factors including the impact of the COVID-19 pandemic, which heightened the need for diabetes management solutions. The pandemic disproportionately affected type-1 diabetes patients, leading to increased usage of insulin pens as patients were advised to monitor their glucose levels more frequently. Additionally, the rising prevalence of diabetes in Europe, coupled with technological advancements in insulin pen devices, contributes to the expanding market size. Despite the challenges posed by the pandemic, manufacturers ensured the continued supply of insulin devices, supporting market growth.

Home Market Analysis Healthcare Research Device Drug Combination Research Drug Filled Devices Research Drug Filled Devices With Needle Research Europe Insulin Pens Market Market Size

Market Size of Europe Insulin Pens Industry

Europe Insulin Pens Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2019 - 2022
CAGR 1.45 %

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Europe Insulin Pens Market Analysis

The Europe Insulin Pens Market size is estimated at USD 2.13 billion in 2023 and is expected to reach USD 2.29 billion by 2028, growing at a CAGR of 1.45% during the forecast period (2023-2028).

The COVID-19 pandemic has substantially impacted the European Insulin Pens Market. Type-1 diabetes patients are impacted more during Covid-19. People with diabetes are having a weak immune system so, with COVID-19, the immune system gets weaker very fast. People with diabetes will have more chances to get into serious complications rather than normal people. The manufacturers have taken care during COVID-19 to deliver insulin devices to diabetes patients with the help of local governments. Doctors around the world suggested diabetes patients should check their diabetes levels more often to be careful and maintain normal blood glucose levels, which led to an increase in the usage of insulin pens.

European countries are suffering from the burden of high diabetes expenditure due to its rising prevalence. Approximately 10% of the total diabetes population has type-1 diabetes and approximately out of this 10% of people only 80-90% use Insulin but the usage of insulin is rising from time to time, even type-2 diabetes patients are using insulin drugs during COVID-19.Technological advancements have increased over the period in Insulin Pens.

Therefore, owing to the aforementioned factors the studied market is anticipated to witness growth over the analysis period.

Europe Insulin Pens Industry Segmentation

An insulin pen is a device used to inject insulin. Mainly two types of insulin pens are available disposable and reusable. The Europe Insulin Pens Market is segmented into Products (Disposable Insulin Pens and Cartridges in Reusable Pens) and Geography (France, Germany, Italy, Rest of Europe, Russia, Spain, and the United Kingdom). The report offers the value (in USD) and volume (in Units) for the above segments. Further, the report will cover a segment-wise breakdown (Value and Volume) for all the countries covered under the Table of Contents.

Product
Disposable Insulin Pens
Cartridges in Reusable Pens
Geography
France
Germany
Italy
Rest of Europe
Russia
Spain
United Kingdom
Need A Different Region Or Segment?
Customize Now

Europe Insulin Pens Market Size Summary

The European insulin pens market is poised for growth, driven by the increasing prevalence of diabetes and advancements in insulin pen technology. The market has been significantly influenced by the COVID-19 pandemic, which highlighted the vulnerability of diabetes patients due to their weakened immune systems. This situation led to a heightened demand for insulin pens as patients were advised to monitor their blood glucose levels more frequently. The rising adoption of insulin pens is further supported by the growing number of diabetes cases in Europe, with a notable increase in type-2 diabetes patients using insulin during the pandemic. Efforts by governments and healthcare organizations to improve diabetes management, such as the National Service Framework program and the Association of British HealthTech Industries' initiatives, are also contributing to market expansion.

Russia holds a significant share of the European insulin pens market, with ongoing efforts to enhance diabetes care through national plans and screening programs. The country's focus on improving reimbursement systems and reducing out-of-pocket expenses is aimed at alleviating the financial burden of diabetes care. Technological innovations have led to the development of more user-friendly insulin delivery devices, boosting their adoption in the Russian market. The market is moderately consolidated, with major global and regional players like Novo Nordisk, Sanofi, and Eli Lilly & Company leading the way. Recent product developments, such as Lilly's Tempo Smart Button and Cequr's Insulin Pen 2.0TM, underscore the ongoing advancements in diabetes technology, further propelling market growth.

Explore More

Europe Insulin Pens Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

    3. 1.3 Market Restraints

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Bargaining Power of Suppliers

      2. 1.4.2 Bargaining Power of Consumers

      3. 1.4.3 Threat of New Entrants

      4. 1.4.4 Threat of Substitute Products and Services

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Product

      1. 2.1.1 Disposable Insulin Pens

      2. 2.1.2 Cartridges in Reusable Pens

    2. 2.2 Geography

      1. 2.2.1 France

      2. 2.2.2 Germany

      3. 2.2.3 Italy

      4. 2.2.4 Rest of Europe

      5. 2.2.5 Russia

      6. 2.2.6 Spain

      7. 2.2.7 United Kingdom

Europe Insulin Pens Market Size FAQs

The Europe Insulin Pens Market is projected to register a CAGR of 1.45% during the forecast period (2024-2029)

Novo Nordisk, Eli Lilly, Biocon, Sanofi and Medtronic are the major companies operating in the Europe Insulin Pens Market.

Europe Insulin Pens Market Report Snapshots

Europe Insulin Pens Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)